GlaxoSmithKline Consumer Nigeria Delisted from NGX
Following formal approval from the Securities and Exchange Commission (SEC) for its proposed scheme of arrangement, GlaxoSmithKline Consumer Nigeria Plc ...
Following formal approval from the Securities and Exchange Commission (SEC) for its proposed scheme of arrangement, GlaxoSmithKline Consumer Nigeria Plc ...
Between July and September 2023, Nigeria witnessed a notable surge in drug imports, totalling N81.81 billion. This reflects a substantial ...
The departure of GlaxoSmithKline (GSK) from the Nigerian pharmaceutical market has triggered a sharp surge in the prices of GSK ...